MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/apt.70614

Медицинская библиотека · Alimentary pharmacology & therapeutics · 2026

Dual Positivity for AMA/AMA-M2 and Anti-gp210/sp100 Shows Highest Diagnostic Value for Primary Biliary Cholangitis.

Liu Hong-Li, Liu Xing, Hu Yi-Fan, Chen Miao-Yang, Li Sha-Sha, Wang Xi-Xuan, Bao Yi-Jun, Zhang Yu, Wang Li, Li Rui-Qi, Chen Shu-Ling, Xiong Qing-Fang, Zhong Yan-Dan, Liu Du-Xian, Zhang Kai, Yang Yong-Feng

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Primary biliary cholangitis (PBC)-related antibodies-including anti-mitochondrial antibodies (AMA), AMA-M2, anti-gp210, and anti-sp100-can occur in non-PBC liver diseases. We evaluated single and combined antibody positivity, focusing on dual positivity, using liver biopsy as the reference standard.

METHODS

This retrospective study included antibody-positive patients who underwent liver biopsy. Patients were classified into three groups: only AMA(s) positive group, only anti-gp210/sp100 positive group, and dual-antibody positive group. Clinical and biochemical characteristics were compared to evaluate diagnostic performance and disease severity. Antibody-positive patients who did not initially meet diagnostic criteria for PBC were followed to assess diagnostic conversion.

RESULTS

Among 733 antibody-positive patients, 80.22% (588/733) were diagnosed with PBC, while 19.78% (145/733) were non-PBC. Diagnostic rates were 80.05% (313/391) in the only AMA(s) positive group, 53.85% (63/117) in the only anti-gp210/sp100 positive group, and 94.22% (212/225) in the dual antibody positive group (p < 0.05). Dual antibody positive patients showed the most severe cholestatic profile, with significantly higher alkaline phosphatase, gamma-glutamyl transferase, total bile acid, and immunoglobulin M levels. The only anti-gp210/sp100 positive group had the highest rate of gastrointestinal bleeding. Autoimmune hepatitis overlap was more common in the dual-positive group than the only AMA(s) positive group (p < 0.05). Among 145 non-PBC patients followed for a median of 39.10 months, 2.07% (3/145) progressed to PBC, with a cumulative incidence of 7.40%.

CONCLUSIONS

Histopathology remains the definitive standard for diagnosing PBC. Dual positivity for AMA/AMA-M2 and anti-gp210/sp100 showed the highest diagnostic value in identifying PBC.

Для цитирования: Liu Hong-Li, Liu Xing, Hu Yi-Fan, Chen Miao-Yang, Li Sha-Sha, Wang Xi-Xuan, Bao Yi-Jun, Zhang Yu, Wang Li, Li Rui-Qi, Chen Shu-Ling, Xiong Qing-Fang, Zhong Yan-Dan, Liu Du-Xian, Zhang Kai, Yang Yong-Feng. Dual Positivity for AMA/AMA-M2 and Anti-gp210/sp100 Shows Highest Diagnostic Value for Primary Biliary Cholangitis.. Alimentary pharmacology & therapeutics. 2026. DOI: 10.1111/apt.70614.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.